Caenazzo A - Search Results

1

Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.

Marchetti M, Barosi G, Balestri F, Viarengo G, Gentili S, Barulli S, Demory JL, Ilariucci F, Volpe A, Bordessoule D, Grossi A, Le Bousse-Kerdiles MC, Caenazzo A, Pecci A, Falcone A, Broccia G, Bendotti C, Bauduer F, Buccisano F, Dupriez B. Marchetti M, et al. Among authors: caenazzo a. J Clin Oncol. 2004 Feb 1;22(3):424-31. doi: 10.1200/JCO.2004.08.160. J Clin Oncol. 2004. PMID: 14752066 Clinical Trial.

2

Pyoderma gangrenosum associated with idiopathic myelofibrosis. Case history.

Sgarabotto D, Vianello F, Valeri P, Tison T, Caenazzo A, Pietrogrande F, Poletti A, Girolami A. Sgarabotto D, et al. Among authors: caenazzo a. Haematologia (Budap). 1993;25(4):249-52. Haematologia (Budap). 1993. PMID: 8157206

3

Idiopathic myelofibrosis serum induces increased DNA synthesis in BALB/c 3T3 cells.

Polato G, Pietrogrande F, Caenazzo A, Piva E, Burlina A, Girolami A. Polato G, et al. Among authors: caenazzo a. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(3):469-73. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990. PMID: 1703119

4

Decreased platelet mitogenic activity in patients with diabetes mellitus.

Caenazzo A, Pietrogrande F, Polato G, Piva E, Sartori D, Girolami A. Caenazzo A, et al. Haematologia (Budap). 1991;24(4):241-7. Haematologia (Budap). 1991. PMID: 1844233

5

Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease.

Caenazzo A, Pietrogrande F, Polato G, Piva E, Masiero M, Sgarabotto D, Girolami A. Caenazzo A, et al. Acta Haematol. 1989;81(3):131-5. doi: 10.1159/000205544. Acta Haematol. 1989. PMID: 2496560

6

A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report.

Pietrogrande F, Caenazzo A, Dazzi F, Polato G, Girolami A. Pietrogrande F, et al. Among authors: caenazzo a. Angiology. 1995 Jul;46(7):633-6. doi: 10.1177/000331979504600712. Angiology. 1995. PMID: 7618768 Review.

7

Serum neopterin levels in haematological malignancies.

Caenazzo A, Pietrogrande F, Sgarabotto D, Dazzi F, Sartori D, Vattamattathil KP, Girolami A. Caenazzo A, et al. Haematologica. 1993 Jul-Aug;78(4):225-9. Haematologica. 1993. PMID: 8294054

8

Hypertriglyceridemia during long-term interferon-alpha therapy in a series of hematologic patients.

Sgarabotto D, Vianello F, Stefani PM, Scano F, Sartori R, Caenazzo A, Girolami A. Sgarabotto D, et al. Among authors: caenazzo a. J Interferon Cytokine Res. 1997 May;17(5):241-4. doi: 10.1089/jir.1997.17.241. J Interferon Cytokine Res. 1997. PMID: 9181461

9

Prevalence and patterns of symptomatic thromboembolism in oncohematology.

Sgarabotto D, Prandoni P, Stefani PM, Scano F, Vianello F, Sartori R, Pietrogrande F, Caenazzo A, Girolami A. Sgarabotto D, et al. Among authors: caenazzo a. Haematologica. 1998 May;83(5):442-6. Haematologica. 1998. PMID: 9658730

10

Intra-cardial thrombosis with systemic and pulmonary embolism as main symptoms in a patient with protein S deficiency.

Girolami A, Simioni P, Sartori MT, Caenazzo A. Girolami A, et al. Among authors: caenazzo a. Blood Coagul Fibrinolysis. 1992 Aug;3(4):485-8. Blood Coagul Fibrinolysis. 1992. PMID: 1420826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters